Company intelligence / Profile preview

Minute Molecular Diagnostics

Evanston, Illinois, United States

Ownership: Private
Employees: ~5
Development stage: Other

Overview

Received FDA Emergency Use Authorization for DASH SARS-CoV-2/S rapid PCR test, providing lab-quality COVID-19 results in 15 minutes at point of care. Adaptation for other infectious diseases in development.

Therapeutic areas: Infectious Diseases
Modalities: DevicePCR-based technology
Industry: Molecular Diagnostics

Partnerships

Northwestern University Center for Innovation in Global Health TechnologiesNIH Rapid Acceleration of Diagnostics (RADx®)National Institute of Biomedical Imaging and BioengineeringJohns Hopkins Center for STD Point-of-Care TestsNIH Point-of-Care Technology Research NetworkCenter for Innovation in Point-of-Care Technology for HIV/AIDS at Northwestern University

Beyond the preview

Go deeper on Minute Molecular Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Minute Molecular Diagnostics.

Explore the full profile